SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-009791
Filing Date
2018-04-30
Accepted
2018-04-30 15:23:17
Documents
45
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apls-10q_20180331.htm 10-Q 1145288
2 EX-31.1 apls-ex311_9.htm EX-31.1 16653
3 EX-31.2 apls-ex312_8.htm EX-31.2 16136
4 EX-32.1 apls-ex321_7.htm EX-32.1 8564
5 EX-32.2 apls-ex322_6.htm EX-32.2 8573
  Complete submission text file 0001564590-18-009791.txt   2584392

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT apls-20180331.xml EX-101.INS 223696
7 XBRL TAXONOMY EXTENSION SCHEMA apls-20180331.xsd EX-101.SCH 27176
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20180331_cal.xml EX-101.CAL 25442
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20180331_def.xml EX-101.DEF 64328
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20180331_lab.xml EX-101.LAB 185087
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20180331_pre.xml EX-101.PRE 135631
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38276 | Film No.: 18789142
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences